Indoco Remedies Limited NSE:INDOCO.NS

Indoco Remedies Limited stock price today

INR 439.4
+107.54
+32.41%
Financial Health
0
1
2
3
4
5
6
7
8
9

Indoco Remedies Limited stock price monthly change

+0.07%
month

Indoco Remedies Limited stock price quarterly change

+0.07%
quarter

Indoco Remedies Limited stock price yearly change

-18.98%
year

Indoco Remedies Limited key metrics

Market Cap
30.39B
Enterprise value
38.75B
P/E
95.41
EV/Sales
2.18
EV/EBITDA
17.70
Price/Sales
1.72
Price/Book
2.80
PEG ratio
0.95
EPS
10.62
Revenue
17.98B
EBITDA
2.55B
Income
984.7M
Revenue Q/Q
4.87%
Revenue Y/Y
9.67%
Profit margin
1.81%
Oper. margin
5.37%
Gross margin
47.96%
EBIT margin
5.37%
EBITDA margin
14.2%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Indoco Remedies Limited stock price history

Indoco Remedies Limited stock forecast

Indoco Remedies Limited financial statements

Indoco Remedies Limited (NSE:INDOCO.NS): Profit margin
Jun 2023 4.16B 243.9M 5.85%
Sep 2023 4.73B 350.8M 7.41%
Dec 2023 4.58B 163M 3.55%
Mar 2024 4.49B 227M 5.05%
Indoco Remedies Limited (NSE:INDOCO.NS): Analyst Estimates
2026 21.87B 1.75B 8.02%
  • Analysts Price target

  • Financials & Ratios estimates

Indoco Remedies Limited (NSE:INDOCO.NS): Earnings per share (EPS)
2024-10-24 1.75 -1.03852
0.45%
Yield TTM
Indoco Remedies Limited (NSE:INDOCO.NS): Payout ratio
Payout ratio 0%
Indoco Remedies Limited (NSE:INDOCO.NS): Dividend Yield
2016 1.23%
2017 0.11%
2019 0.6%
2020 0.17%
2022 0.4%
Indoco Remedies Limited (NSE:INDOCO.NS): Debt to assets
Jun 2023 0 0
Sep 2023 19380400000 8.67B 44.77%
Dec 2023 0 0
Mar 2024 21447300000 10.34B 48.22%
Indoco Remedies Limited (NSE:INDOCO.NS): Cash Flow
Jun 2023 397.6M 0 0
Sep 2023 428.2M 0 0
Dec 2023 487M 0 0
Mar 2024 0 0 0

Indoco Remedies Limited alternative data

Indoco Remedies Limited (NSE:INDOCO.NS): Employee count
Aug 2023 6,000
Sep 2023 6,000
Oct 2023 6,000
Nov 2023 6,000
Dec 2023 6,000
Jan 2024 6,000
Feb 2024 6,000
Mar 2024 6,000
Apr 2024 6,000
May 2024 6,000
Jun 2024 6,000
Jul 2024 6,000

Indoco Remedies Limited other data

Insider Compensation
Mr. Suresh Govind Kare (1939) Executive Chairman
$34,840,000
Ms. Aditi Milind Panandikar (1970) MD & Executive Director
$30,000,000
Mr. Sundeep Vasant Bambolkar (1960) Joint MD & Executive Director
$27,810,000
Mr. Jayshankar Menon (1965) Company Sec., Compliance Officer & Assistant Vice President of Legal
$3,310,000
  • What's the price of Indoco Remedies Limited stock today?

    One share of Indoco Remedies Limited stock can currently be purchased for approximately $439.4.

  • When is Indoco Remedies Limited's next earnings date?

    Indoco Remedies Limited is estimated to report earnings on Wednesday, 22 Oct 2025.

  • Does Indoco Remedies Limited pay dividends?

    Yes, Indoco Remedies Limited pays dividends and its trailing 12-month yield is 0.45% with 0% payout ratio. The last Indoco Remedies Limited stock dividend of $0 was paid on 6 Sep 2025.

  • How much money does Indoco Remedies Limited make?

    Indoco Remedies Limited has a market capitalization of 30.39B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 18.92% to 17.88B US dollars. Indoco Remedies Limited earned 984.6M US dollars in net income (profit) last year or -$1.04 on an earnings per share basis.

  • What is Indoco Remedies Limited's stock symbol?

    Indoco Remedies Limited is traded on the NSE under the ticker symbol "INDOCO.NS".

  • What is Indoco Remedies Limited's primary industry?

    Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.

  • How do i buy shares of Indoco Remedies Limited?

    Shares of Indoco Remedies Limited can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Indoco Remedies Limited's key executives?

    Indoco Remedies Limited's management team includes the following people:

    • Mr. Suresh Govind Kare Executive Chairman(age: 86, pay: $34,840,000)
    • Ms. Aditi Milind Panandikar MD & Executive Director(age: 55, pay: $30,000,000)
    • Mr. Sundeep Vasant Bambolkar Joint MD & Executive Director(age: 65, pay: $27,810,000)
    • Mr. Jayshankar Menon Company Sec., Compliance Officer & Assistant Vice President of Legal(age: 60, pay: $3,310,000)
  • How many employees does Indoco Remedies Limited have?

    As Jul 2024, Indoco Remedies Limited employs 6,000 workers.

  • When Indoco Remedies Limited went public?

    Indoco Remedies Limited is publicly traded company for more then 20 years since IPO on 14 Jan 2005.

  • What is Indoco Remedies Limited's official website?

    The official website for Indoco Remedies Limited is indoco.com.

  • How can i contact Indoco Remedies Limited?

    Indoco Remedies Limited can be reached via phone at +91 22 6287 1000.

Indoco Remedies Limited company profile:

Indoco Remedies Limited

indoco.com
Exchange:

NSE

Full time employees:

6,000

Industry:

Drug Manufacturers - Specialty & Generic

Sector:

Healthcare

Indoco Remedies Limited manufactures and sells formulations and active pharmaceutical ingredients in India and internationally. The company offers respiratory products, such as Karvol Plus, Febrex Plus, and Tuspel; stomatologicals products that include Sensodent-K, Sensoform Toothpaste, Sensoform Gum Paint, Rexidin M, Rexidin SRS, RR Sensoform Dental, Snowdent, Kidodent, Rexidin Plus, and Dentogel; gastrointestinal products, such as Carmicide, Cyclopam, Cyclomeff, and Nosic; pain/analgesics products that include Lignox and T-lac; and ophthal/otologicals products, such as Renolen, Homide, Dexoren – S, Zincoren, Otorex, Mofloren-D, and Mofloren LP. It also provides vitamins/minerals/nutrients that include Methycal, Cital UTI, SM Fibro, Cal Aid, SM Fibro, MCBM DHA, and Apispur; urology products, such as Carmicide and Cital; Cloben G and Scabex for dermatology; ATM for anti-infectives; Hemsyl for blood related; MCBM 69 and D Chiro for gynecological; and Spear for anti-haemorrhoidal. In addition, the company provides analytical services, such as impurity profile, particle size analysis, heavy metal analysis, polymorphism and compatibility studies, extractables and leachables studies, lyophilization studies, reference and working standards, forced degradation studies, and chromatographic method development and validation services. Further, it offers services that include architectural design, lighting, mechanical and utility engineering, project and construction management, electrical, control system, piping, structural design, data transfer system, and process engineering. The company serves general practitioners, pediatricians, consultant physicians, dentists, cardiologists, diabetologists, endocrinologists, gynaecologists, and ophthalmologists. The company was formerly known as Indo Continental Trading Company. Indoco Remedies Limited was founded in 1945 and is based in Mumbai, India.

Indoco House
Mumbai, 400098

:
ISIN: INE873D01024
CUSIP: Y3939C106